BofA Securities Downgrades Fulcrum Therapeutics (FULC) to Underperform
Tweet Send to a Friend
(Updated - September 12, 2024 10:58 AM EDT)
BofA Securities analyst Tazeen Ahmad downgraded Fulcrum Therapeutics (NASDAQ: FULC) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
BofA Securities analyst Tazeen Ahmad downgraded Fulcrum Therapeutics (NASDAQ: FULC) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
